All Biotech News

List of articles in category All Biotech News
Title	Published Date
Pfizer Ventures and TVM Life Science Ventures VII Announce Additional Investment in Ixchelsis Ltd.	12/05/2016
Agendia’s MammaPrint® and BluePrint® Tests Highlighted in Multiple Presentations at the 2016 San Antonio Breast Cancer Symposium, Adding Further Clinical Utility	12/02/2016
New Vetter Data Processing Center is Officially Certified	11/30/2016
Orchard Therapeutics Announces Strategic Alliance with Oxford BioMedica	11/29/2016
Orchard Therapeutics and UCLA Receive USD20 Million in Latest Round of Funding from California’s Stem Cell Agency	11/23/2016
RedHill Biopharma Announces YELIVA™ (ABC294640) Poster Presentation at the 2016 EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium	11/21/2016
Independent Clinical Study Shows Adherium’s Smartinhaler™ Dramatically Improves Clinical Outcomes and Medication Adherence in Children with Asthma	11/17/2016
Zytoprotec Phase II Peritoneal Dialysis Study: Last Patient Out	11/14/2016
Prospective Clinical Follow-Up Study with Over 2,200 Patients Confirms High Test Accuracy of Prenatest® for Fetal Trisomies	11/14/2016
Xellia Pharmaceuticals Commences Packaging and Distribution Operations at Cleveland Site after Successful FDA Inspection	11/14/2016
RedHill Biopharma Reports Positive FDA Type B Meeting on RHB-105 for H. pylori Infection Ahead of Confirmatory Phase III Study	11/10/2016
Sartorius Stedim Biotech Opens New Bioanalytical Testing Laboratory in Boston	11/10/2016
PSR Orphan Experts Launches Patient Organization Advisory Board	11/08/2016
AdAlta Licenses Alzheimer's Disease-Specific Shark Antibodies to Crossbeta Biosciences for Therapeutic and Diagnostic Development	11/08/2016
Agendia’s Proven Breast Cancer Recurrence Assay, MammaPrint, Now Available in the Middle East	11/08/2016
Changes in the AYOXXA Management Team	11/07/2016
AdAlta and XL-protein Announce Collaboration to Develop a Long Acting Version of Its Lead Fibrosis Drug Candidate AD-114 Using PASylation® Technology	11/07/2016
Mucosis Initiates First-in-Human Study of SynGEM®, a Needle-Free Nasal Spray RSV Vaccine	11/07/2016
Atriva Therapeutics Announces Upcoming US Patent Issuance for MEK Treatment against Viral Diseases	11/04/2016
ARTES and BioSun Announce Co-Development for HPV Vaccine	11/04/2016
RedHill Biopharma Provides Update on Ongoing Phase III and Phase II Studies with BEKINDA® and Expected Timing of Top-Line Results	11/03/2016
NBE Therapeutics Raises CHF 20 Million in Series B Funding	11/03/2016
RedHill Biopharma Announces Proposed Public Offering of its American Depository Shares	11/02/2016
Agendia Announces the Award of a New Category 1 CPT Code from the American Medical Association for the MammaPrint® 70-Gene Breast Cancer Recurrence Assay	11/01/2016
Atomo Diagnostics Receives Grant to Develop New, Innovative HIV Self-Test Solution	10/27/2016
Agendia Expands its Business Activities in Germany	10/26/2016
BioPharmaSpec Appoints Two Senior Technical Staff from the CRO and Biosimilar Fields	10/25/2016
SOTIO and NBE Therapeutics Sign Collaboration and License Agreement for Next-Generation Antibody-Drug Conjugates	10/20/2016
Synaffix Enters into a Commercial License Agreement with ADC Therapeutics	10/20/2016
RedHill Biopharma Announces Allowance of a Patent in Japan Supporting RHB-104 for Multiple Sclerosis	10/18/2016

Page 40 of 84